These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33577603)

  • 1. Intermedilysin cytolytic activity depends on heparan sulfates and membrane composition.
    Drabavicius G; Daelemans D
    PLoS Genet; 2021 Feb; 17(2):e1009387. PubMed ID: 33577603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disentangling the roles of cholesterol and CD59 in intermedilysin pore formation.
    Boyd CM; Parsons ES; Smith RA; Seddon JM; Ces O; Bubeck D
    Sci Rep; 2016 Dec; 6():38446. PubMed ID: 27910935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for recognition of the pore-forming toxin intermedilysin by human complement receptor CD59.
    Johnson S; Brooks NJ; Smith RA; Lea SM; Bubeck D
    Cell Rep; 2013 May; 3(5):1369-77. PubMed ID: 23665225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermedilysin-receptor interactions during assembly of the pore complex: assembly intermediates increase host cell susceptibility to complement-mediated lysis.
    LaChapelle S; Tweten RK; Hotze EM
    J Biol Chem; 2009 May; 284(19):12719-26. PubMed ID: 19293153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the action of the superfamily of cholesterol-dependent cytolysins from studies of intermedilysin.
    Polekhina G; Giddings KS; Tweten RK; Parker MW
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):600-5. PubMed ID: 15637162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol-dependent cytolysins: The outstanding questions.
    Johnstone BA; Joseph R; Christie MP; Morton CJ; McGuiness C; Walsh JC; Böcking T; Tweten RK; Parker MW
    IUBMB Life; 2022 Dec; 74(12):1169-1179. PubMed ID: 35836358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cholesterol-dependent cytolysin family of gram-positive bacterial toxins.
    Heuck AP; Moe PC; Johnson BB
    Subcell Biochem; 2010; 51():551-77. PubMed ID: 20213558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific protein-membrane contacts are required for prepore and pore assembly by a cholesterol-dependent cytolysin.
    Soltani CE; Hotze EM; Johnson AE; Tweten RK
    J Biol Chem; 2007 May; 282(21):15709-16. PubMed ID: 17412689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diversity of receptor recognition in cholesterol-dependent cytolysins.
    Tabata A; Ohkura K; Ohkubo Y; Tomoyasu T; Ohkuni H; Whiley RA; Nagamune H
    Microbiol Immunol; 2014 Mar; 58(3):155-71. PubMed ID: 24401114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cholesterol-dependent cytolysin signature motif: a critical element in the allosteric pathway that couples membrane binding to pore assembly.
    Dowd KJ; Farrand AJ; Tweten RK
    PLoS Pathog; 2012; 8(7):e1002787. PubMed ID: 22792065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9.
    Wickham SE; Hotze EM; Farrand AJ; Polekhina G; Nero TL; Tomlinson S; Parker MW; Tweten RK
    J Biol Chem; 2011 Jun; 286(23):20952-62. PubMed ID: 21507937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytolytic activity of vaginolysin strictly depends on cholesterol and is potentiated by human CD59.
    Zilnyte M; Venclovas Č; Zvirbliene A; Pleckaityte M
    Toxins (Basel); 2015 Jan; 7(1):110-28. PubMed ID: 25590277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for tuning activity and membrane specificity of bacterial cytolysins.
    Shah NR; Voisin TB; Parsons ES; Boyd CM; Hoogenboom BW; Bubeck D
    Nat Commun; 2020 Nov; 11(1):5818. PubMed ID: 33199689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Basis for Receptor Recognition by the Human CD59-Responsive Cholesterol-Dependent Cytolysins.
    Lawrence SL; Gorman MA; Feil SC; Mulhern TD; Kuiper MJ; Ratner AJ; Tweten RK; Morton CJ; Parker MW
    Structure; 2016 Sep; 24(9):1488-98. PubMed ID: 27499440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin.
    Giddings KS; Zhao J; Sims PJ; Tweten RK
    Nat Struct Mol Biol; 2004 Dec; 11(12):1173-8. PubMed ID: 15543155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis of human specific cytolysin intermedilysin aiming application to cancer immunotherapy.
    Ohkura K; Nagamune H; Kourai H
    Anticancer Res; 2004; 24(5C):3343-53. PubMed ID: 15515430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol-Dependent Cytolysins Produced by Vaginal Bacteria: Certainties and Controversies.
    Pleckaityte M
    Front Cell Infect Microbiol; 2019; 9():452. PubMed ID: 31998661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-Wide CRISPR-Cas9 Screen Does Not Identify Host Factors Modulating Streptococcus agalactiae β-Hemolysin/Cytolysin-Induced Cell Death.
    Shahi I; Llaneras CN; Perelman SS; Torres VJ; Ratner AJ
    Microbiol Spectr; 2022 Feb; 10(1):e0218621. PubMed ID: 35196804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and phylogenetic characterization of Vaginolysin, the human-specific cytolysin from Gardnerella vaginalis.
    Gelber SE; Aguilar JL; Lewis KL; Ratner AJ
    J Bacteriol; 2008 Jun; 190(11):3896-903. PubMed ID: 18390664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiles of ILY, VLY and Sm-hPAF interaction with human CD59.
    Kawaguchi Y; Tabata A; Nagamune H; Ohkura K
    Anticancer Res; 2013 Jul; 33(7):2901-4. PubMed ID: 23780977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.